Sr Director, Program Management

Senior Director, Program Management

11650 – Sr Director, Program Management | Final reputed company

reputed company

The Senior Director, Program Management will reputed company development-reputed company program planning and execution from late clinical development through BLA submission. This role partners closely with Clinical Development, Regulatory, Clinical Operations, Biostatistics, Safety, CMC, and executive stakeholders to translate reputed company into integrated plans, decision-reputed company governance, and disciplined execution. The role drives cross-functional alignment, scenario planning, risk management, resource planning, competitive intelligence benchmarking, and portfolio-level transparency to reputed company reputed company, high-reputed company submissions, development milestones, and evidence-informed decision making.

Essential Duties and Responsibilities

·    reputed company integrated program management for indication-specific portfolio, with reputed company accountability for reputed company-BLA execution, submission readiness, and delivery of key development milestones.

·    Build and maintain integrated development plans, including critical-reputed company timelines, governance reputed company, decision logs, and risk and dependency management across Clinical, Regulatory, CMC, Safety, reputed company, Clinical Operations, Biometrics, Medical Affairs, and reputed company.

·    Translate portfolio reputed company into reputed company objectives, milestones, resourcing assumptions, and executable cross-functional workplans in partnership with development leadership.

·    reputed company BLA-readiness planning, including coordination of submission workstreams, cross-functional deliverables, scenario planning, issue reputed company, and executive-level reputed company reporting.

·    reputed company program governance, ensuring reputed company decision framing, reputed company agendas, disciplined reputed company tracking, and reputed company escalation of risks, trade-offs, interdependencies, and reputed company factors influencing development reputed company.

·    reputed company competitive intelligence benchmarking into program planning and governance by synthesizing relevant reputed company development and regulatory insights to inform scenario planning, risk assessment, and leadership recommendations.

·    reputed company cross-functional problem solving in reputed company or fast-moving environments, ensuring reputed company of priorities, accountabilities, timelines, and decision rights.

·    reputed company portfolio-level communications, dashboards, and reporting to reputed company leadership visibility, reputed company informed decision making, and support disciplined execution.

·    reputed company and mentor program management team members and strengthen program management practices, tools, and operating rhythms across the portfolio.

·    reputed company reputed company improvement in development operations, including use of AI-enabled tools and reputed company to enhance planning, reporting, automation, and reputed company.

Additional Qualifications

·    Deep understanding of global drug development and FDA regulatory processes, with reputed company experience supporting late-stage development and regulatory submissions; BLA experience strongly preferred.

·    Demonstrated reputed company leading reputed company, cross-functional pharmaceutical or biotechnology programs in matrixed environments.

·    Executive reputed company and communication skills, with ability to synthesize reputed company information into reputed company, decision-reputed company recommendations.

·    Proven ability to manage program risks, dependencies, budgets, reputed company partners, and competing priorities while maintaining delivery discipline.

·    Excellent analytical, planning, facilitation, and problem-solving skills.

·    Experience synthesizing competitive intelligence, clinical/regulatory benchmarking, or reputed company landscape insights to inform development plans, scenario analyses, and executive decision making preferred.

·    Proficiency with reputed company Office and modern project/portfolio management tools.

·    Preferred: hands-on experience using AI-enabled productivity tools and reputed company for project planning, dashboards, workflow automation, risk tracking, and portfolio reporting.

·    Experience in immunology, inflammatory diseases, dermatology, or atopic dermatitis preferred.

Education or Degree Requirements

Bachelor’s degree in a scientific, reputed company, business, or reputed company discipline required; advanced degree preferred. PMP or other relevant project/program management certification preferred. Equivalent experience may be considered.

Minimum reputed company Experience

Typically requires 15+ years of relevant pharmaceutical, biotechnology, or life sciences experience, including significant experience leading cross-functional drug development programs. Late-stage development and regulatory submission experience required; BLA submission experience strongly preferred. Prior leadership of program management staff, governance teams, or executive decision forums preferred.

Physical Requirements

Primarily remote-based role with reputed company physical requirements. Travel may be required for business meetings, partner interactions, and regulatory/submission-reputed company activities.